메뉴 건너뛰기




Volumn 44, Issue 2, 1999, Pages 129-136

Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status

Author keywords

Antiangiogenesis; Glioma model; Suramine

Indexed keywords

HOE 33342; PIMONIDAZOLE; SURAMIN;

EID: 0032804144     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006363215260     Document Type: Article
Times cited : (33)

References (38)
  • 1
    • 84975525035 scopus 로고
    • Clinical applications of research on angiogenesis
    • Folkman J: Clinical applications of research on angiogenesis. New Engl J Med 333: 1757-1763, 1995
    • (1995) New Engl J Med , vol.333 , pp. 1757-1763
    • Folkman, J.1
  • 2
    • 0023909330 scopus 로고
    • Determinants of tumor blood flow: A review
    • Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658, 1988
    • (1988) Cancer Res , vol.48 , pp. 2641-2658
    • Jain, R.K.1
  • 3
    • 0024408986 scopus 로고
    • Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: A review
    • Vaupel P, Kallinowski F, Okunieff P: Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465, 1989
    • (1989) Cancer Res , vol.49 , pp. 6449-6465
    • Vaupel, P.1    Kallinowski, F.2    Okunieff, P.3
  • 4
    • 0028028308 scopus 로고
    • Angiogenesis inhibition: A review
    • Auerbach W, Auerbach R: Angiogenesis inhibition: a review. Pharmac Ther 63: 265-311, 1994
    • (1994) Pharmac Ther , vol.63 , pp. 265-311
    • Auerbach, W.1    Auerbach, R.2
  • 5
    • 0028912119 scopus 로고
    • Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy
    • Fan TD, Jaggar R, Bicknell R: Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57-66, 1995
    • (1995) Trends Pharmacol Sci , vol.16 , pp. 57-66
    • Fan, T.D.1    Jaggar, R.2    Bicknell, R.3
  • 9
    • 0028318791 scopus 로고
    • Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding to basic fibroblast growth factor, migration, proliferation and induction of urokinase-type plasminogen activator
    • Takano S, Gately S, Neville ME, Herblin W, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S: Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding to basic fibroblast growth factor, migration, proliferation and induction of urokinase-type plasminogen activator. Cancer Res 54: 2654-2660, 1994
    • (1994) Cancer Res , vol.54 , pp. 2654-2660
    • Takano, S.1    Gately, S.2    Neville, M.E.3    Herblin, W.4    Gross, J.L.5    Engelhard, H.6    Perricone, M.7    Eidsvoog, K.8    Brem, S.9
  • 12
    • 0015291143 scopus 로고
    • Tumor angiogenesis: A quantitative method for histologic grading
    • Brem SS, Cotran R, Folkman J: Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48: 347-356, 1972
    • (1972) J Natl Cancer Inst , vol.48 , pp. 347-356
    • Brem, S.S.1    Cotran, R.2    Folkman, J.3
  • 13
    • 0029994483 scopus 로고    scopus 로고
    • Tumor oxygenation: A matter of supply and demand
    • Gulledge CJ, Dewhirst MW: Tumor oxygenation: a matter of supply and demand. Anticancer Res 16: 741-750, 1996
    • (1996) Anticancer Res , vol.16 , pp. 741-750
    • Gulledge, C.J.1    Dewhirst, M.W.2
  • 16
    • 0029150035 scopus 로고
    • Application of an image analysis system for the quantitation of the tumor perfusion and vascularity in human glioma xenografts
    • Rijken PFJW, Bernsen HJJA, van der Kogel AJ: Application of an image analysis system for the quantitation of the tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 50: 141-153, 1995
    • (1995) Microvasc Res , vol.50 , pp. 141-153
    • Rijken, P.F.J.W.1    Bernsen, H.J.J.A.2    Van Der Kogel, A.J.3
  • 17
    • 0030940609 scopus 로고    scopus 로고
    • Suramin: A molecule with a broad spectrum of biological and therapeutical properties
    • Baghdiguian S, Fantini J: Suramin: a molecule with a broad spectrum of biological and therapeutical properties. Cancer J 10: 31-37, 1997
    • (1997) Cancer J , vol.10 , pp. 31-37
    • Baghdiguian, S.1    Fantini, J.2
  • 18
    • 0026352044 scopus 로고
    • Receptors for platelet derived growth factor in human glioma lines and influence of suramin on cell proliferation
    • Westphal M, Ackerman E, Hoppe J, Herrmann HD: Receptors for platelet derived growth factor in human glioma lines and influence of suramin on cell proliferation. J Neuro-Oncol 11: 207-213, 1991
    • (1991) J Neuro-Oncol , vol.11 , pp. 207-213
    • Westphal, M.1    Ackerman, E.2    Hoppe, J.3    Herrmann, H.D.4
  • 19
    • 0026729378 scopus 로고
    • Suramin prevents neovascularization and tumor growth through blocking of fibroblast growth factor activity
    • Pesenti E, Sola F, Mongelli N, Grandi M, Spreafico F: Suramin prevents neovascularization and tumor growth through blocking of fibroblast growth factor activity. Br J Cancer 66: 367-372, 1992
    • (1992) Br J Cancer , vol.66 , pp. 367-372
    • Pesenti, E.1    Sola, F.2    Mongelli, N.3    Grandi, M.4    Spreafico, F.5
  • 21
    • 0027162784 scopus 로고
    • Suramin, an anticancer drug with unique biological effects
    • Larsen AK: Suramin, an anticancer drug with unique biological effects. Cancer Chemother Pharmacol 32: 96-98, 1993
    • (1993) Cancer Chemother Pharmacol , vol.32 , pp. 96-98
    • Larsen, A.K.1
  • 22
    • 0028345444 scopus 로고
    • A structure-activity analysis of antagonism of growth factor and angiogenesis activity of basic fibroblast growth factor by suramin and related polyanions
    • Braddock PS, Hu DE, Fan TPD, Stratford IJ, Harris AL, Bicknell R: A structure-activity analysis of antagonism of growth factor and angiogenesis activity of basic fibroblast growth factor by suramin and related polyanions. Br J Cancer 69: 890-898, 1994
    • (1994) Br J Cancer , vol.69 , pp. 890-898
    • Braddock, P.S.1    Hu, D.E.2    Fan, T.P.D.3    Stratford, I.J.4    Harris, A.L.5    Bicknell, R.6
  • 23
    • 0030198685 scopus 로고    scopus 로고
    • Suramin is a potent inhibitor of vascular endothelial growth factor. a contribution to the molecular basis of its antiangiogenic action
    • Waltenberger J, Mayr U, Frank H, Hombach V: Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol 28: 1523-1529, 1996
    • (1996) J Mol Cell Cardiol , vol.28 , pp. 1523-1529
    • Waltenberger, J.1    Mayr, U.2    Frank, H.3    Hombach, V.4
  • 24
    • 0029397222 scopus 로고
    • Angiogenesis in malignant gliomas
    • Plate KH, Risau W: Angiogenesis in malignant gliomas. Glia 15: 339-347, 1995
    • (1995) Glia , vol.15 , pp. 339-347
    • Plate, K.H.1    Risau, W.2
  • 25
    • 0029074334 scopus 로고
    • Suramin inhibits C6 glioma-induced angiogenesis in vitro
    • Coomber BL: Suramin inhibits C6 glioma-induced angiogenesis in vitro. J Cell Biochem 58: 199-207, 1995
    • (1995) J Cell Biochem , vol.58 , pp. 199-207
    • Coomber, B.L.1
  • 26
    • 0028044984 scopus 로고
    • The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma
    • Olson JJ, Polk DM, Reisner A: The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma. Neurosurgery 34: 297-308, 1994
    • (1994) Neurosurgery , vol.34 , pp. 297-308
    • Olson, J.J.1    Polk, D.M.2    Reisner, A.3
  • 29
    • 0028111148 scopus 로고
    • Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: Potent inhibition of angiogenesis
    • Taki T, Ohnishi T, Arita N, Hiaga S, Saitoh Y, Izumotot S, Mori K, Hayakawa T: Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of angiogenesis. J Neuro-Oncol 19: 251-258, 1994
    • (1994) J Neuro-Oncol , vol.19 , pp. 251-258
    • Taki, T.1    Ohnishi, T.2    Arita, N.3    Hiaga, S.4    Saitoh, Y.5    Izumotot, S.6    Mori, K.7    Hayakawa, T.8
  • 30
    • 0029949160 scopus 로고    scopus 로고
    • Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
    • Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK: Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci 93: 14765-14770, 1996
    • (1996) Proc Natl Acad Sci , vol.93 , pp. 14765-14770
    • Yuan, F.1    Chen, Y.2    Dellian, M.3    Safabakhsh, N.4    Ferrara, N.5    Jain, R.K.6
  • 32
    • 0031909427 scopus 로고    scopus 로고
    • The effect of the anti-angiogenic agent AGM-1470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice
    • Bernsen HJJA, Rijken PFJW, Peters H, Bakker H, van der Kogel AJ: The effect of the anti-angiogenic agent AGM-1470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice. J Neuro-Oncol 38: 51-57, 1998
    • (1998) J Neuro-Oncol , vol.38 , pp. 51-57
    • Bernsen, H.J.J.A.1    Rijken, P.F.J.W.2    Peters, H.3    Bakker, H.4    Van Der Kogel, A.J.5
  • 34
    • 0030920374 scopus 로고    scopus 로고
    • Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents
    • Kakeji Y, Teicher BA: Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Investigational New Drugs 15: 39-48, 1997
    • (1997) Investigational New Drugs , vol.15 , pp. 39-48
    • Kakeji, Y.1    Teicher, B.A.2
  • 35
    • 0029875694 scopus 로고    scopus 로고
    • Uptake of tenozolomide in a rat glioma model in presence or absence of the angiogenesis inhibitor TNP-470
    • Devineni D, Kleinszanto A, Gallo JM: Uptake of tenozolomide in a rat glioma model in presence or absence of the angiogenesis inhibitor TNP-470. Cancer Res 56: 1983-1987, 1996
    • (1996) Cancer Res , vol.56 , pp. 1983-1987
    • Devineni, D.1    Kleinszanto, A.2    Gallo, J.M.3
  • 36
    • 0028840752 scopus 로고
    • Antiproliferative and angiostatic activity of suramine analogues
    • Firsching A, Nickel P, Mor AP, Allolio B: Antiproliferative and angiostatic activity of suramine analogues. Cancer Res 55: 4957-4962, 1995
    • (1995) Cancer Res , vol.55 , pp. 4957-4962
    • Firsching, A.1    Nickel, P.2    Mor, A.P.3    Allolio, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.